Author: <span>Mesothelioma News</span>

Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the…

Several chemotherapeutics exert immunomodulatory effects. One of these is the nucleoside analogue gemcitabine, which is widely used in patients with lung cancer, ovarian cancer, breast cancer, mesothelioma and several other types of cancer, but with li…

Auto-antibodies to I2-F1-ATPase and vimentin in malignant mesothelioma.

Patients with Malignant Mesothelioma develop unidentified auto-antibodies to MM tumour antigens. This study was conducted to identify the targets of MM patient auto-antibodies in order to try to understand more of the anti-tumour response and to determ…

Asbestos Containing Pipes have some Jamaican Residents Demanding Action

In addition to concerns over asbestos containing cement pipes, many homes, businesses and institutions can still be found with asbestos containing materials both on the inside and on the outside of the buildings. published a story about residents from …

Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma , a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall…

Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma , a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall…